🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects of atezolizumab, varlilumab, an...
Status
Terminated
Location
Rutgers Cancer Institute of New Jersey
Start Date
2019-09-11
Trial ID
NCT04081688
Treatments Being Tested
This is a single-arm Phase Ib/II multicenter open-label study, with transla...
Status
Completed
Location
ICO Badalona
Start Date
2021-03-17
Trial ID
NCT04487756
Treatments Being Tested
This research is studying two experimental drugs, abemaciclib and atezolizu...
Status
Withdrawn
Location
Dana-Farber Cancer Institute
Start Date
2020-10
Trial ID
NCT04272645
Treatments Being Tested
This is a Phase II open-label trial of neoadjuvant immunochemotherapy with ...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2025-06-15
Trial ID
NCT05870800
This is an open-label, multicenter, Phase 1a study to evaluate the safety, ...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2021-09-07
Trial ID
NCT04975958
Treatments Being Tested
The study "A MultIceNTER Phase I Peptide VaCcine Trial to Exploit NeoePitop...
Status
Active Not Recruiting
Location
Department of Neurology and Polyclinic, Universitiy Clinic Heidelberg
Start Date
2023-02-15
Trial ID
NCT04808245
Treatments Being Tested
This is a Phase Ib/II, multicenter, open-label study to evaluate the safety...
Status
Completed
Location
The First Affiliated Hospital of Wannan Medical College
Start Date
2022-04-13
Trial ID
NCT05253053
Treatments Being Tested
In early breast cancer (eBC), pathological complete response (pCR) after ne...
Status
Recruiting
Location
National Center for Tumor Diseases
Start Date
2023-06-29
Trial ID
NCT05332561
This is a multicentric double-blind, placebo controlled, phase III trial. I...
Status
Recruiting
Location
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Irccs
Start Date
2021-12-14
Trial ID
NCT04996017
Treatments Being Tested
Neoadjuvant plus adjuvant treatment with target therapy and immunotherapy g...
Status
Active Not Recruiting
Location
Ospedale S.M. Annunziata - Azienda USL Toscana Centro
Start Date
2020-12-03
Trial ID
NCT04722575